Arrestin Development: Emerging Roles for β-arrestins in Developmental Signaling Pathways

Developmental Cell

Volumn 17, Issue 4, 2009, Pages 443-458

  Kovacs, Jeffrey J ^a   Hara, Makoto R ^a   Davenport, Chandra L ^a   Kim, Jihee ^a   Lefkowitz, Robert J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CYTOKINE; FRIZZLED PROTEIN; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NOTCH RECEPTOR; PROTEIN KINASE B; SMOOTHENED PROTEIN; SOMATOMEDIN C RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; WNT1 PROTEIN;

DEVELOPMENTAL BIOLOGY; EMBRYO DEVELOPMENT; ENDOCYTOSIS; ENZYME ACTIVITY; GENE SILENCING; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ARRESTINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 70349986967     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devcel.2009.09.011     Document Type: Review

References (172)

1. Ahn S., Shenoy S.K., Wei H., and Lefkowitz R.J. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 279 (2004) 35518-35525
2. Ahn S., Kim J., Hara M.R., Ren X.R., and Lefkowitz R.J. {beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation. J. Biol. Chem. 284 (2009) 8855-8865
3. Barnes W.G., Reiter E., Violin J.D., Ren X.R., Milligan G., and Lefkowitz R.J. beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J. Biol. Chem. 280 (2005) 8041-8050
4. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., and Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. USA 101 (2004) 5099-5104
5. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122 (2005) 261-273
6. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., Wetsel W.C., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132 (2008) 125-136
7. Berthouze M., Venkataramanan V., Li Y., and Shenoy S.K. The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J. 28 (2009) 1684-1696
8. Bhandari D., Trejo J., Benovic J.L., and Marchese A. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J. Biol. Chem. 282 (2007) 36971-36979
9. Bohn L.M., Lefkowitz R.J., Gainetdinov R.R., Peppel K., Caron M.G., and Lin F.T. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286 (1999) 2495-2498
10. Bohn L.M., Gainetdinov R.R., Lin F.T., Lefkowitz R.J., and Caron M.G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408 (2000) 720-723
11. Bondi C.D., McKeon R.M., Bennett J.M., Ignatius P.F., Brydon L., Jockers R., Melan M.A., and Witt-Enderby P.A. MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation. J. Pineal Res. 44 (2008) 288-298
12. Bruchas M.R., Macey T.A., Lowe J.D., and Chavkin C. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J. Biol. Chem. 281 (2006) 18081-18089
13. Bryja V., Gradl D., Schambony A., Arenas E., and Schulte G. Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc. Natl. Acad. Sci. USA 104 (2007) 6690-6695
14. Bryja V., Schambony A., Cajanek L., Dominguez I., Arenas E., and Schulte G. Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep. 9 (2008) 1244-1250
15. Buchanan F.G., Gorden D.L., Matta P., Shi Q., Matrisian L.M., and DuBois R.N. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. USA 103 (2006) 1492-1497
16. Camina J.P., Lodeiro M., Ischenko O., Martini A.C., and Casanueva F.F. Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins. J. Cell. Physiol. 213 (2007) 187-200
17. Cano D.A., Murcia N.S., Pazour G.J., and Hebrok M. Orpk mouse model of polycystic kidney disease reveals essential role of primary cilia in pancreatic tissue organization. Development 131 (2004) 3457-3467
18. Caunt C.J., Finch A.R., Sedgley K.R., Oakley L., Luttrell L.M., and McArdle C.A. Arrestin-mediated ERK activation by gonadotropin-releasing hormone receptors: receptor-specific activation mechanisms and compartmentalization. J. Biol. Chem. 281 (2006) 2701-2710
19. Charest P.G., Oligny-Longpre G., Bonin H., Azzi M., and Bouvier M. The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling. Cell. Signal. 19 (2007) 32-41
20. Chen W., Hu L.A., Semenov M.V., Yanagawa S., Kikuchi A., Lefkowitz R.J., and Miller W.E. beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins. Proc. Natl. Acad. Sci. USA 98 (2001) 14889-14894
21. Chen W., Kirkbride K.C., How T., Nelson C.D., Mo J., Frederick J.P., Wang X.F., Lefkowitz R.J., and Blobe G.C. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301 (2003) 1394-1397
22. Chen W., ten Berge D., Brown J., Ahn S., Hu L.A., Miller W.E., Caron M.G., Barak L.S., Nusse R., and Lefkowitz R.J. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301 (2003) 1391-1394
23. Chen W., Ren X.R., Nelson C.D., Barak L.S., Chen J.K., Beachy P.A., de Sauvage F., and Lefkowitz R.J. Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 306 (2004) 2257-2260
24. Chen J., Rusnak M., Lombroso P.J., and Sidhu A. Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. Eur. J. Neurosci. 29 (2009) 287-306
25. Chen M.H., Wilson C.W., Li Y.J., Law K.K., Lu C.S., Gacayan R., Zhang X., Hui C.C., and Chuang P.T. Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev. 23 (2009) 1910-1928
26. Chitnis M.M., Yuen J.S., Protheroe A.S., Pollak M., and Macaulay V.M. The type 1 insulin-like growth factor receptor pathway. Clin. Cancer Res. 14 (2008) 6364-6370
27. Christensen S.T., Pedersen S.F., Satir P., Veland I.R., and Schneider L. The primary cilium coordinates signaling pathways in cell cycle control and migration during development and tissue repair. Curr. Top. Dev. Biol. 85 (2008) 261-301
28. Collins B.M., Norwood S.J., Kerr M.C., Mahony D., Seaman M.N., Teasdale R.D., and Owen D.J. Structure of Vps26B and mapping of its interaction with the retromer protein complex. Traffic 9 (2008) 366-379
29. Conner D.A., Mathier M.A., Mortensen R.M., Christe M., Vatner S.F., Seidman C.E., and Seidman J.G. beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res. 81 (1997) 1021-1026
30. Corbit K.C., Aanstad P., Singla V., Norman A.R., Stainier D.Y., and Reiter J.F. Vertebrate Smoothened functions at the primary cilium. Nature 437 (2005) 1018-1021
31. Corbit K.C., Shyer A.E., Dowdle W.E., Gaulden J., Singla V., Chen M.H., Chuang P.T., and Reiter J.F. Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and non-ciliary mechanisms. Nat. Cell Biol. 10 (2008) 70-76
32. Dalle S., Ricketts W., Imamura T., Vollenweider P., and Olefsky J.M. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276 (2001) 15688-15695
33. Dalle S., Imamura T., Rose D.W., Worrall D.S., Ugi S., Hupfeld C.J., and Olefsky J.M. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1. Mol. Cell. Biol. 22 (2002) 6272-6285
34. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
35. Defea K. Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br. J. Pharmacol. 153 Suppl 1 (2008) S298-S309
36. DeFea K.A., Zalevsky J., Thoma M.S., Dery O., Mullins R.D., and Bunnett N.W. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Cell Biol. 148 (2000) 1267-1281
37. DeWire S.M., Ahn S., Lefkowitz R.J., and Shenoy S.K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69 (2007) 483-510
38. DeWire S.M., Kim J., Whalen E.J., Ahn S., Chen M., and Lefkowitz R.J. Beta-arrestin-mediated signaling regulates protein synthesis. J. Biol. Chem. 283 (2008) 10611-10620
39. Dupont J., and Holzenberger M. IGF type 1 receptor: a cell cycle progression factor that regulates aging. Cell Cycle 2 (2003) 270-272
40. Eggenschwiler J.T., and Anderson K.V. Cilia and developmental signaling. Annu. Rev. Cell Dev. Biol. 23 (2007) 345-373
41. Feng X.H., and Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21 (2005) 659-693
42. Finger E.C., Lee N.Y., You H.J., and Blobe G.C. Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation. J. Biol. Chem. 283 (2008) 34808-34818
43. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., and Pei G. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14 (2004) 303-317
44. Ge L., Ly Y., Hollenberg M., and DeFea K. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem. 278 (2003) 34418-34426
45. Ge H., Krishnan P., Liu L., Krishnan B., Davis R.L., Hardin P.E., and Roman G. A Drosophila nonvisual arrestin is required for the maintenance of olfactory sensitivity. Chem. Senses 31 (2006) 49-62
46. Gesty-Palmer D., Chen M., Reiter E., Ahn S., Nelson C.D., Wang S., Eckhardt A.E., Cowan C.L., Spurney R.F., Luttrell L.M., and Lefkowitz R.J. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J. Biol. Chem. 281 (2006) 10856-10864
47. Girnita L., Shenoy S.K., Sehat B., Vasilcanu R., Girnita A., Lefkowitz R.J., and Larsson O. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J. Biol. Chem. 280 (2005) 24412-24419
48. Girnita L., Shenoy S.K., Sehat B., Vasilcanu R., Vasilcanu D., Girnita A., Lefkowitz R.J., and Larsson O. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J. Biol. Chem. 282 (2007) 11329-11338
49. Goel R., Phillips-Mason P.J., Raben D.M., and Baldassare J.J. alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. J. Biol. Chem. 277 (2002) 18640-18648
50. Gong K., Li Z., Xu M., Du J., Lv Z., and Zhang Y. A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J. Biol. Chem. 283 (2008) 29028-29036
51. Gordon K.J., and Blobe G.C. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim. Biophys. Acta 1782 (2008) 197-228
52. Gurevich E.V., and Gurevich V.V. Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol. 7 (2006) 236
53. Hammerschmidt M., and McMahon A.P. The effect of pertussis toxin on zebrafish development: a possible role for inhibitory G-proteins in hedgehog signaling. Dev. Biol. 194 (1998) 166-171
54. Harper J.A., Yuan J.S., Tan J.B., Visan I., and Guidos C.J. Notch signaling in development and disease. Clin. Genet. 64 (2003) 461-472
55. Hirokawa N. Stirring up development with the heterotrimeric kinesin KIF3. Traffic 1 (2000) 29-34
56. Hoffmann C., Ziegler N., Reiner S., Krasel C., and Lohse M.J. Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. J. Biol. Chem. 283 (2008) 30933-30941
57. Huang P., and Schier A.F. Dampened Hedgehog signaling but normal Wnt signaling in zebrafish without cilia. Development 136 (2009) 3089-3098
58. Huangfu D., and Anderson K.V. Cilia and Hedgehog responsiveness in the mouse. Proc. Natl. Acad. Sci. USA 102 (2005) 11325-11330
59. Huangfu D., and Anderson K.V. Signaling from Smo to Ci/Gli: conservation and divergence of Hedgehog pathways from Drosophila to vertebrates. Development 133 (2006) 3-14
60. Huangfu D., Liu A., Rakeman A.S., Murcia N.S., Niswander L., and Anderson K.V. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 426 (2003) 83-87
61. Hunton D.L., Barnes W.G., Kim J., Ren X.R., Violin J.D., Reiter E., Milligan G., Patel D.D., and Lefkowitz R.J. Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol. Pharmacol. 67 (2005) 1229-1236
62. Hupfeld C.J., Resnik J.L., Ugi S., and Olefsky J.M. Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors. J. Biol. Chem. 280 (2005) 1016-1023
63. Iacovelli L., Capobianco L., D'Ancona G.M., Picascia A., and De Blasi A. Regulation of lysophosphatidic acid receptor-stimulated response by G-protein-coupled receptor kinase-2 and beta-arrestin1 in FRTL-5 rat thyroid cells. J. Endocrinol. 174 (2002) 103-110
64. Ingham P.W., and McMahon A.P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15 (2001) 3059-3087
65. Jadrich J.L., O'Connor M.B., and Coucouvanis E. The TGF beta activated kinase TAK1 regulates vascular development in vivo. Development 133 (2006) 1529-1541
66. Jiang Q., Yan Z., and Feng J. Activation of group III metabotropic glutamate receptors attenuates rotenone toxicity on dopaminergic neurons through a microtubule-dependent mechanism. J. Neurosci. 26 (2006) 4318-4328
67. Jiang J., and Hui C.C. Hedgehog signaling in development and cancer. Dev. Cell 15 (2008) 801-812
68. Johnson E.C., Tift F.W., McCauley A., Liu L., and Roman G. Functional characterization of kurtz, a Drosophila non-visual arrestin, reveals conservation of GPCR desensitization mechanisms. Insect Biochem. Mol. Biol. 38 (2008) 1016-1022
69. Kang J., Shi Y., Xiang B., Qu B., Su W., Zhu M., Zhang M., Bao G., Wang F., Zhang X., et al. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123 (2005) 833-847
70. Kara E., Crepieux P., Gauthier C., Martinat N., Piketty V., Guillou F., and Reiter E. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol. Endocrinol. 20 (2006) 3014-3026
71. Katanaev V.L., Ponzielli R., Semeriva M., and Tomlinson A. Trimeric G protein-dependent frizzled signaling in Drosophila. Cell 120 (2005) 111-122
72. Kawasaki A., Torii K., Yamashita Y., Nishizawa K., Kanekura K., Katada M., Ito M., Nishimoto I., Terashita K., Aiso S., and Matsuoka M. Wnt5a promotes adhesion of human dermal fibroblasts by triggering a phosphatidylinositol-3 kinase/Akt signal. Cell. Signal. 19 (2007) 2498-2506
73. Kim G.H., and Han J.K. Essential role for beta-arrestin 2 in the regulation of Xenopus convergent extension movements. EMBO J. 26 (2007) 2513-2526
74. Kim S.E., Cho J.Y., Kim K.S., Lee S.J., Lee K.H., and Choi K.Y. Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells. Cell. Signal. 16 (2004) 1309-1317
75. Kim G.H., Her J.H., and Han J.K. Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements. J. Cell Biol. 182 (2008) 1073-1082
76. Kim I.M., Tilley D.G., Chen J., Salazar N.C., Whalen E.J., Violin J.D., and Rockman H.A. Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. Proc. Natl. Acad. Sci. USA 105 (2008) 14555-14560
77. Kim J., Ahn S., Rajagopal K., and Lefkowitz R.J. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J. Biol. Chem. 284 (2009) 11953-11962
78. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93 (1996) 8455-8459
79. Kohn A.D., and Moon R.T. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38 (2005) 439-446
80. Kohout T.A., and Lefkowitz R.J. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63 (2003) 9-18
81. Kopan R., and Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137 (2009) 216-233
82. Kovacs J.J., Whalen E.J., Liu R., Xiao K., Kim J., Chen M., Wang J., Chen W., and Lefkowitz R.J. Beta-arrestin-mediated localization of smoothened to the primary cilium. Science 320 (2008) 1777-1781
83. Labasque M., Reiter E., Becamel C., Bockaert J., and Marin P. Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. Mol. Biol. Cell 19 (2008) 4640-4650
84. Lakshmikanthan V., Zou L., Kim J.I., Michal A., Nie Z., Messias N.C., Benovic J.L., and Daaka Y. Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc. Natl. Acad. Sci. USA 106 (2009) 9379-9384
85. Laviola L., Natalicchio A., and Giorgino F. The IGF-I signaling pathway. Curr. Pharm. Des. 13 (2007) 663-669
86. Lee N.Y., and Blobe G.C. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J. Biol. Chem. 282 (2007) 21507-21517
87. Lee N.Y., Kirkbride K.C., Sheu R.D., and Blobe G.C. The TGF-{beta} Type III Receptor Mediates Distinct Subcellular Trafficking and Downstream Signaling of ALK3 and ALK6 Receptors. Mol. Biol. Cell (2009) 10.1091/mbc.E1009-1007-0539 in press
88. Lefkowitz R.J., and Whalen E.J. beta-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol. 16 (2004) 162-168
89. Lefkowitz R.J., Rajagopal K., and Whalen E.J. New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell 24 (2006) 643-652
90. Li X., Baillie G.S., and Houslay M.D. Mdm2 Directs the Ubiquitination of {beta}-Arrestin-sequestered cAMP Phosphodiesterase-4D5. J. Biol. Chem. 284 (2009) 16170-16182
91. Lin F.T., Daaka Y., and Lefkowitz R.J. beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J. Biol. Chem. 273 (1998) 31640-31643
92. Lin F., Hiesberger T., Cordes K., Sinclair A.M., Goldstein L.S., Somlo S., and Igarashi P. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. USA 100 (2003) 5286-5291
93. Lin C.H., MacGurn J.A., Chu T., Stefan C.J., and Emr S.D. Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135 (2008) 714-725
94. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
95. Luan B., Zhao J., Wu H., Duan B., Shu G., Wang X., Li D., Jia W., Kang J., and Pei G. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457 (2009) 1146-1149
96. Luo J., Busillo J.M., and Benovic J.L. M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol. Pharmacol. 74 (2008) 338-347
97. Luttrell D.K., and Luttrell L.M. Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases. Assay Drug Dev. Technol. 1 (2003) 327-338
98. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., Lin F., Kawakatsu H., Owada K., Luttrell D.K., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283 (1999) 655-661
99. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., and Lefkowitz R.J. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98 (2001) 2449-2454
100. Ma L., and Pei G. Beta-arrestin signaling and regulation of transcription. J. Cell Sci. 120 (2007) 213-218
101. Macey T.A., Lowe J.D., and Chavkin C. Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons. J. Biol. Chem. 281 (2006) 34515-34524
102. Martin N.P., Lefkowitz R.J., and Shenoy S.K. Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination. J. Biol. Chem. 278 (2003) 45954-45959
103. May S.R., Ashique A.M., Karlen M., Wang B., Shen Y., Zarbalis K., Reiter J., Ericson J., and Peterson A.S. Loss of the retrograde motor for IFT disrupts localization of Smo to cilia and prevents the expression of both activator and repressor functions of Gli. Dev. Biol. 287 (2005) 378-389
104. Massague J., and Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19 (2000) 1745-1754
105. Matsuno K., Diederich R.J., Go M.J., Blaumueller C.M., and Artavanis-Tsakonas S. Deltex acts as a positive regulator of Notch signaling through interactions with the Notch ankyrin repeats. Development 121 (1995) 2633-2644
106. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., Davis R.J., and Lefkowitz R.J. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290 (2000) 1574-1577
107. McLaughlin N.J., Banerjee A., Kelher M.R., Gamboni-Robertson F., Hamiel C., Sheppard F.R., Moore E.E., and Silliman C.C. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J. Immunol. 176 (2006) 7039-7050
108. McLennan G.P., Kiss A., Miyatake M., Belcheva M.M., Chambers K.T., Pozek J.J., Mohabbat Y., Moyer R.A., Bohn L.M., and Coscia C.J. Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways. J. Neurochem. 107 (2008) 1753-1765
109. Meloni A.R., Fralish G.B., Kelly P., Salahpour A., Chen J.K., Wechsler-Reya R.J., Lefkowitz R.J., and Caron M.G. Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol. Cell. Biol. 26 (2006) 7550-7560
110. Milasta S., Evans N.A., Ormiston L., Wilson S., Lefkowitz R.J., and Milligan G. The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochem. J. 387 (2005) 573-584
111. Miller W.E., Houtz D.A., Nelson C.D., Kolattukudy P.E., and Lefkowitz R.J. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. J. Biol. Chem. 278 (2003) 21663-21671
112. Molla-Herman A., Boularan C., Ghossoub R., Scott M.G., Burtey A., Zarka M., Saunier S., Concordet J.P., Marullo S., and Benmerah A. Targeting of beta-arrestin2 to the centrosome and primary cilium: role in cell proliferation control. PLoS ONE 3 (2008) e3728
113. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
114. Mukherjee A., Veraksa A., Bauer A., Rosse C., Camonis J., and Artavanis-Tsakonas S. Regulation of Notch signalling by non-visual beta-arrestin. Nat. Cell Biol. 7 (2005) 1191-1201
115. Mukhopadhyay D., and Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315 (2007) 201-205
116. Murone M., Rosenthal A., and de Sauvage F.J. Hedgehog signal transduction: from flies to vertebrates. Exp. Cell Res. 253 (1999) 25-33
117. Mythreye K., and Blobe G.C. The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc. Natl. Acad. Sci. USA 106 (2009) 8221-8226
118. Nelson C.D., Perry S.J., Regier D.S., Prescott S.M., Topham M.K., and Lefkowitz R.J. Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. Science 315 (2007) 663-666
119. Nelson C.D., Kovacs J.J., Nobles K.N., Whalen E.J., and Lefkowitz R.J. Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated sequestration of the beta2-adrenergic receptor. J. Biol. Chem. 238 (2008) 21093-21101
120. Ocbina P.J., Tuson M., and Anderson K.V. Primary cilia are not required for normal canonical Wnt signaling in the mouse embryo. PLoS ONE 4 (2009) e6839
121. Ogden S.K., Fei D.L., Schilling N.S., Ahmed Y.F., Hwa J., and Robbins D.J. G protein Galphai functions immediately downstream of Smoothened in Hedgehog signalling. Nature 456 (2008) 967-970
122. Ozawa K., Whalen E.J., Nelson C.D., Mu Y., Hess D.T., Lefkowitz R.J., and Stamler J.S. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol. Cell 31 (2008) 395-405
123. Park T.J., Mitchell B.J., Abitua P.B., Kintner C., and Wallingford J.B. Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat. Genet. 40 (2008) 871-879
124. Perry S.J., Baillie G.S., Kohout T.A., McPhee I., Magiera M.M., Ang K.L., Miller W.E., McLean A.J., Conti M., Houslay M.D., and Lefkowitz R.J. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 298 (2002) 834-836
125. Philipp M., Fralish G.B., Meloni A.R., Chen W., MacInnes A.W., Barak L.S., and Caron M.G. Smoothened signaling in vertebrates is facilitated by a G protein-coupled receptor kinase. Mol. Biol. Cell 19 (2008) 5478-5489
126. Pierce K.L., Maudsley S., Daaka Y., Luttrell L.M., and Lefkowitz R.J. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 97 (2000) 1489-1494
127. Premont R.T., and Gainetdinov R.R. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol. 69 (2007) 511-534
128. Ren X.R., Reiter E., Ahn S., Kim J., Chen W., and Lefkowitz R.J. Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl. Acad. Sci. USA 102 (2005) 1448-1453
129. Roman G., He J., and Davis R.L. kurtz, a novel nonvisual arrestin, is an essential neural gene in Drosophila. Genetics 155 (2000) 1281-1295
130. Ross A.J., May-Simera H., Eichers E.R., Kai M., Hill J., Jagger D.J., Leitch C.C., Chapple J.P., Munro P.M., Fisher S., et al. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat. Genet. 37 (2005) 1135-1140
131. Salcedo A., Mayor Jr. F., and Penela P. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J. 25 (2006) 4752-4762
132. Schlessinger K., Hall A., and Tolwinski N. Wnt signaling pathways meet Rho GTPases. Genes Dev. 23 (2009) 265-277
133. Schmid C.L., Raehal K.M., and Bohn L.M. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc. Natl. Acad. Sci. USA 105 (2008) 1079-1084
134. Scott M.G., Pierotti V., Storez H., Lindberg E., Thuret A., Muntaner O., Labbe-Jullie C., Pitcher J.A., and Marullo S. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol. Cell. Biol. 26 (2006) 3432-3445
135. Shenoy S.K. Seven-transmembrane receptors and ubiquitination. Circ. Res. 100 (2007) 1142-1154
136. Shenoy S.K., and Lefkowitz R.J. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J. Biol. Chem. 278 (2003) 14498-14506
137. Shenoy S.K., McDonald P.H., Kohout T.A., and Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294 (2001) 1307-1313
138. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., Reiter E., Premont R.T., Lichtarge O., and Lefkowitz R.J. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281 (2006) 1261-1273
139. Shenoy S.K., Barak L.S., Xiao K., Ahn S., Berthouze M., Shukla A.K., Luttrell L.M., and Lefkowitz R.J. Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J. Biol. Chem. 282 (2007) 29549-29562
140. Shenoy S.K., Xiao K., Venkataramanan V., Snyder P.M., Freedman N.J., and Weissman A.M. Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J. Biol. Chem. 283 (2008) 22166-22176
141. Shenoy S.K., Modi A.S., Shukla A.K., Xiao K., Berthouze M., Ahn S., Wilkinson K.D., Miller W.E., and Lefkowitz R.J. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc. Natl. Acad. Sci. USA 106 (2009) 6650-6655
142. Shi H., Rojas R., Bonifacino J.S., and Hurley J.H. The retromer subunit Vps26 has an arrestin fold and binds Vps35 through its C-terminal domain. Nat. Struct. Mol. Biol. 13 (2006) 540-548
143. Shibuya H., Iwata H., Masuyama N., Gotoh Y., Yamaguchi K., Irie K., Matsumoto K., Nishida E., and Ueno N. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J. 17 (1998) 1019-1028
144. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., Lee K.Y., Bussey C., Steckel M., Tanaka N., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19 (2005) 2668-2681
145. Siddle K., Urso B., Niesler C.A., Cope D.L., Molina L., Surinya K.H., and Soos M.A. Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem. Soc. Trans. 29 (2001) 513-525
146. Sonoda N., Imamura T., Yoshizaki T., Babendure J.L., Lu J.C., and Olefsky J.M. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc. Natl. Acad. Sci. USA 105 (2008) 6614-6619
147. Sorrentino A., Thakur N., Grimsby S., Marcusson A., von Bulow V., Schuster N., Zhang S., Heldin C.H., and Landstrom M. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat. Cell Biol. 10 (2008) 1199-1207
148. Sun Y., Cheng Z., Ma L., and Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277 (2002) 49212-49219
149. Takeyama K., Aguiar R.C., Gu L., He C., Freeman G.J., Kutok J.L., Aster J.C., and Shipp M.A. The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity. J. Biol. Chem. 278 (2003) 21930-21937
150. Thoma C.R., Frew I.J., Hoerner C.R., Montani M., Moch H., and Krek W. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat. Cell Biol. 9 (2007) 588-595
151. Tohgo A., Pierce K.L., Choy E.W., Lefkowitz R.J., and Luttrell L.M. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277 (2002) 9429-9436
152. Varjosalo M., Li S.P., and Taipale J. Divergence of hedgehog signal transduction mechanism between Drosophila and mammals. Dev. Cell 10 (2006) 177-186
153. Wagner E.F., and Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9 (2009) 537-549
154. Walters R.W., Shukla A.K., Kovacs J.J., Violin J.D., DeWire S.M., Lam C.M., Chen J.R., Muehlbauer M.J., Whalen E.J., and Lefkowitz R.J. beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J. Clin. Invest. 119 (2009) 1312-1321
155. Wang P., and DeFea K.A. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45 (2006) 9374-9385
156. Wang H.Y., Liu T., and Malbon C.C. Structure-function analysis of Frizzleds. Cell. Signal. 18 (2006) 934-941
157. Wang Q., Lu R., Zhao J., and Limbird L.E. Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J. Biol. Chem. 281 (2006) 25948-25955
158. Wang Y., Tang Y., Teng L., Wu Y., Zhao X., and Pei G. Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7 (2006) 139-147
159. Watanabe D., Saijoh Y., Nonaka S., Sasaki G., Ikawa Y., Yokoyama T., and Hamada H. The left-right determinant Inversin is a component of node monocilia and other 9+0 cilia. Development 130 (2003) 1725-1734
160. Wilbanks A.M., Fralish G.B., Kirby M.L., Barak L.S., Li Y.X., and Caron M.G. Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science 306 (2004) 2264-2267
161. Wu M.Y., and Hill C.S. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16 (2009) 329-343
162. Xiao K., McClatchy D.B., Shukla A.K., Zhao Y., Chen M., Shenoy S.K., Yates III J.R., and Lefkowitz R.J. Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc. Natl. Acad. Sci. USA 104 (2007) 12011-12016
163. Yam P.T., Langlois S.D., Morin S., and Charron F. Sonic hedgehog guides axons through a noncanonical, Src-family-kinase-dependent signaling pathway. Neuron 62 (2009) 349-362
164. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., and Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270 (1995) 2008-2011
165. Yamashita M., Fatyol K., Jin C., Wang X., Liu Z., and Zhang Y.E. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol. Cell 31 (2008) 918-924
166. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
167. You H.J., How T., and Blobe G.C. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. Carcinogenesis 30 (2009) 1281-1287
168. Yun M.S., Kim S.E., Jeon S.H., Lee J.S., and Choi K.Y. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J. Cell Sci. 118 (2005) 313-322
169. Zhang Y.E. Non-Smad pathways in TGF-beta signaling. Cell Res. 19 (2009) 128-139
170. Zhang J., Ferguson S.S., Barak L.S., Aber M.J., Giros B., Lefkowitz R.J., and Caron M.G. Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors Channels 5 (1997) 193-199
171. Zidar D.A., Violin J.D., Whalen E.J., and Lefkowitz R.J. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc. Natl. Acad. Sci. USA 106 (2009) 9649-9654
172. Zoudilova M., Kumar P., Ge L., Wang P., Bokoch G.M., and DeFea K.A. Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J. Biol. Chem. 282 (2007) 20634-20646